Alzheimer’s disease: Modeling current and potential targets
By the time we are 65, one in ten of us will have contracted Alzheimer’s disease. This rises to fifty ...
According to Martin Slater, Director of Consulting at Cresset Biomolecular Discovery, there are two main factors driving the current increasing trend to outsource computational chemistry: first, a trend to outsource across the discovery spectrum. “The increasing fragmentation of the drug discovery business has brought an increase in companies that can move quickly to offer tailored research, often through the use of on demand services from consultants”. The second factor is that big pharma are seeking to reduce their R&D costs as many key patents are due to expire over the coming years.
This article appears in the January/February 2013 edition of sp2 Inter-Active magazine: The Advantages of Outsourcing Computational Chemistry (Part 2).
The first part of this article, The Advantages of Outsourcing Computational Chemistry (Part 1), appeared in the November/December 2012 issue of sp2 Inter-Active.